BritePear› 🍐 Peptide You› NAD+ & NMN
Peptide You · Cellular Energy & Longevity
NMN/NR: Supplement, No Rx Required

NAD+ and NMN: The Energy Crisis in Your Cells

Why the coenzyme your mitochondria depend on declines with age, and what the science says about restoring it.

🍐 Pear It Down ,

NAD+ is a coenzyme found in every cell, essential for energy metabolism, DNA repair, and sirtuin activation. NAD+ levels decline significantly with age, obesity, and metabolic disease. NMN and NR are precursors that raise NAD+ levels, available as supplements with growing human trial data. This intersects directly with GLP-1 biology.

Not medical advice. Educational information reflecting personal research and transparency. Intravenous NAD+ protocols require medical supervision. Always work with a qualified healthcare provider.

Technically, NAD+ is not a peptide. It's a coenzyme. But it belongs in the Peptide You curriculum because it's foundational to understanding why your cells age and why metabolic health matters at the cellular level. It also intersects directly with GLP-1 biology in ways worth understanding.

What It Is

The Coenzyme Your Cells Cannot Live Without

Nicotinamide adenine dinucleotide (NAD+) is present in every living cell. It functions as an electron carrier in cellular respiration, the process by which your mitochondria convert nutrients into ATP. Without adequate NAD+, your mitochondria cannot function efficiently.[1]

But NAD+ does more than energy metabolism. It's also a required substrate for sirtuins, a family of proteins sometimes called "longevity genes." Sirtuins regulate inflammation, DNA repair, and metabolic efficiency. They need NAD+ to function. No NAD+, no sirtuin activity.[2]

The Problem

Why It Declines

NAD+ levels drop significantly with age. By middle age, most people have roughly half the NAD+ of a young adult. Obesity, metabolic syndrome, and chronic inflammation accelerate this decline further.[3] This creates a cycle: lower NAD+ means less efficient energy metabolism and less sirtuin activity, which contributes to more metabolic dysfunction, which further depletes NAD+.

For someone who has carried significant weight for years and is now actively losing it, this cellular energy context is directly relevant, not abstract biology.

"David Sinclair at Harvard has called NAD+ decline a key driver of aging and has published extensively on NAD+ restoration as a longevity strategy. His work has moved this from fringe to mainstream research conversation in under a decade."

The Precursors

NMN and NR

NMN (Nicotinamide Mononucleotide)

NMN has been at the center of most longevity-focused research. Human clinical trials have confirmed that oral NMN supplementation raises blood NAD+ levels in a dose-dependent manner with a favorable safety profile.[5] A 2021 randomized controlled trial in Japan showed 250mg/day NMN over 12 weeks significantly increased NAD+ in older men and improved muscle function metrics.[6]

NR (Nicotinamide Riboside)

NR is further along in human trial data. Multiple randomized trials have confirmed it raises NAD+ levels reliably, with favorable safety profiles. Studies in older adults have shown improvements in blood pressure, inflammation markers, and insulin sensitivity.[7]

The Connection

NAD+ and GLP-1 Therapy

This is underappreciated: GLP-1 medications and NAD+ metabolism intersect. Metabolic syndrome is associated with both NAD+ depletion and GLP-1 receptor pathway dysfunction. As GLP-1 medications improve metabolic function, the NAD+ system's capacity to support that recovery matters. Some researchers are now exploring combination approaches.[8]

⚠ FDA / Regulatory StatusNMN and NR are available as over-the-counter dietary supplements and do not require a prescription. Intravenous NAD+ infusions require medical supervision and are typically administered in clinical settings. The FDA does not regulate NMN/NR supplements for efficacy. As with all supplements, quality varies significantly, look for third-party tested products.
Cliff's Note

This is one of the areas where I've moved from curious to personally engaged. The NAD+ research is substantial enough, and the connection to GLP-1 therapy close enough, that I consider this part of the metabolic health conversation rather than fringe longevity speculation. NMN and NR as supplements have a reasonable safety profile and growing human evidence. That's a different risk category than injectable peptides, and worth distinguishing.

Sources & Citations

  1. Yoshino J, et al. (2018). NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism, 27(3), 513–528.
  2. Guarente L (2013). Calorie restriction and sirtuins revisited. Genes & Development, 27(19), 2072–2085.
  3. Zhu XH, et al. (2015). In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain. PNAS, 112(9), 2876–2881.
  4. Mills KF, et al. (2016). Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metabolism, 24(6), 795–806.
  5. Irie J, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters. Endocrine Journal, 67(2), 153–160.
  6. Igarashi M, et al. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ levels. NPJ Aging, 8(1), 5.
  7. Trammell SA, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in healthy humans. Nature Communications, 7, 12948.
  8. Yoshino M, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229.